See more : The Anup Engineering Limited (ANUP.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Chr. Hansen Holding A/S (CHYHY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chr. Hansen Holding A/S, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Vertu Motors plc (VTMTF) Income Statement Analysis – Financial Results
- EncounterCare Solutions, Inc. (ECSL) Income Statement Analysis – Financial Results
- Hubei Geoway Investment Co.,Ltd. (600462.SS) Income Statement Analysis – Financial Results
- PT Eterindo Wahanatama Tbk (ETWA.JK) Income Statement Analysis – Financial Results
- Canadian Palladium Resources Inc. (DCNNF) Income Statement Analysis – Financial Results
Chr. Hansen Holding A/S (CHYHY)
About Chr. Hansen Holding A/S
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. It operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.33B | 1.22B | 1.08B | 970.00M | 1.16B | 1.10B | 1.06B | 948.90M | 858.60M | 756.20M | 738.40M | 698.70M | 635.60M | 575.50M | 511.20M | 476.69M | 444.78M |
| Cost of Revenue | 610.12M | 541.50M | 464.00M | 386.00M | 511.10M | 496.80M | 484.40M | 443.50M | 412.20M | 364.90M | 353.60M | 339.10M | 326.90M | 290.40M | 269.12M | 247.80M | 241.32M |
| Gross Profit | 722.14M | 676.50M | 613.40M | 584.00M | 650.00M | 600.60M | 578.10M | 505.40M | 446.40M | 391.30M | 384.80M | 359.60M | 308.70M | 285.10M | 242.08M | 228.89M | 203.47M |
| Gross Profit Ratio | 54.20% | 55.54% | 56.93% | 60.21% | 55.98% | 54.73% | 54.41% | 53.26% | 51.99% | 51.75% | 52.11% | 51.47% | 48.57% | 49.54% | 47.36% | 48.02% | 45.75% |
| Research & Development | 99.64M | 96.80M | 90.10M | 76.20M | 79.40M | 73.40M | 71.40M | 62.50M | 51.00M | 43.20M | 42.90M | 35.70M | 28.20M | 25.00M | 22.54M | 22.13M | 23.08M |
| General & Administrative | 86.00M | 82.00M | 73.10M | 53.30M | 71.10M | 70.40M | 70.90M | 65.90M | 61.30M | 53.90M | 55.80M | 51.60M | 46.10M | 44.40M | 41.40M | 39.56M | 36.10M |
| Selling & Marketing | 182.90M | 173.90M | 154.80M | 135.10M | 158.50M | 139.30M | 134.20M | 112.70M | 101.70M | 92.70M | 96.10M | 89.60M | 78.90M | 73.10M | 66.02M | 65.44M | 63.08M |
| SG&A | 268.47M | 255.90M | 227.90M | 188.40M | 229.60M | 209.70M | 205.10M | 178.60M | 163.00M | 146.60M | 151.90M | 141.20M | 125.00M | 117.50M | 107.42M | 104.99M | 99.18M |
| Other Expenses | 0.00 | -2.00M | -2.70M | -7.50M | -2.20M | -2.70M | -5.50M | -3.50M | -100.00K | -3.30M | -2.50M | -2.30M | -3.70M | -700.00K | -1.76M | -1.48M | -2.01M |
| Operating Expenses | 368.11M | 350.70M | 315.30M | 257.10M | 306.80M | 280.40M | 271.00M | 237.60M | 213.90M | 186.50M | 192.30M | 174.60M | 149.50M | 141.80M | 128.19M | 125.64M | 120.26M |
| Cost & Expenses | 978.24M | 892.20M | 779.30M | 643.10M | 817.90M | 777.20M | 755.40M | 681.10M | 626.10M | 551.40M | 545.90M | 513.70M | 476.40M | 432.20M | 397.31M | 373.44M | 361.57M |
| Interest Income | 29.00M | 2.20M | 1.90M | 3.70M | 5.10M | 1.60M | 400.00K | 700.00K | 800.00K | 900.00K | 500.00K | 32.40M | 37.60M | 38.70M | 9.57M | 41.30M | 32.75M |
| Interest Expense | 28.95M | 10.50M | 20.40M | 13.10M | 14.30M | 8.70M | 8.00M | 8.70M | 7.40M | 8.40M | 7.30M | 45.10M | 48.50M | 105.70M | 116.10M | 112.50M | 115.02M |
| Depreciation & Amortization | 113.72M | 101.10M | 112.50M | 92.50M | 69.00M | 63.80M | 61.00M | 56.20M | 53.90M | 51.90M | 56.50M | 50.50M | 42.50M | 62.90M | 40.58M | 48.81M | 40.94M |
| EBITDA | 467.75M | 405.20M | 374.20M | 387.18M | 364.76M | 371.40M | 362.10M | 318.80M | 283.30M | 246.20M | 242.10M | 267.90M | 239.30M | 182.00M | 152.98M | 144.55M | 115.96M |
| EBITDA Ratio | 35.11% | 34.65% | 36.08% | 41.80% | 35.30% | 33.68% | 34.08% | 33.60% | 34.20% | 33.69% | 32.79% | 38.34% | 37.65% | 31.62% | 32.09% | 30.32% | 26.07% |
| Operating Income | 354.03M | 320.90M | 276.20M | 313.00M | 340.90M | 320.20M | 305.70M | 255.60M | 232.50M | 195.10M | 192.50M | 185.00M | 159.20M | 119.10M | 109.41M | 95.74M | 75.03M |
| Operating Income Ratio | 26.57% | 26.35% | 25.64% | 32.27% | 29.36% | 29.18% | 28.77% | 26.94% | 27.08% | 25.80% | 26.07% | 26.48% | 25.05% | 20.70% | 21.40% | 20.08% | 16.87% |
| Total Other Income/Expenses | -46.53M | -28.00M | -51.00M | -17.40M | 10.10M | -24.10M | -16.20M | -30.40M | -12.80M | -22.50M | -15.80M | -13.00M | -10.90M | -67.00M | -106.53M | -71.20M | -82.27M |
| Income Before Tax | 307.51M | 292.90M | 247.10M | 295.60M | 324.80M | 296.10M | 290.90M | 239.40M | 219.70M | 181.30M | 176.70M | 172.30M | 148.30M | 52.10M | 2.88M | 24.54M | -7.25M |
| Income Before Tax Ratio | 23.08% | 24.05% | 22.93% | 30.47% | 27.97% | 26.98% | 27.38% | 25.23% | 25.59% | 23.98% | 23.93% | 24.66% | 23.33% | 9.05% | 0.56% | 5.15% | -1.63% |
| Income Tax Expense | 70.19M | 67.80M | 48.40M | 64.00M | 74.60M | 67.90M | 66.90M | 55.60M | 57.20M | 49.10M | 36.90M | 41.00M | 34.10M | 32.40M | 18.84M | 17.30M | -1.21M |
| Net Income | 226.64M | 225.10M | 198.70M | 245.00M | 250.20M | 228.20M | 224.00M | 183.80M | 162.50M | 132.20M | 137.80M | 129.30M | 118.60M | 19.20M | -18.36M | 43.58M | -12.75M |
| Net Income Ratio | 17.01% | 18.48% | 18.44% | 25.26% | 21.55% | 20.79% | 21.08% | 19.37% | 18.93% | 17.48% | 18.66% | 18.51% | 18.66% | 3.34% | -3.59% | 9.14% | -2.87% |
| EPS | 1.72 | 0.43 | 0.38 | 0.47 | 0.47 | 0.43 | 0.43 | 0.35 | 0.31 | 0.25 | 0.26 | 0.24 | 0.22 | 0.04 | -0.05 | 0.08 | -0.02 |
| EPS Diluted | 1.72 | 0.43 | 0.38 | 0.47 | 0.47 | 0.43 | 0.42 | 0.35 | 0.31 | 0.25 | 0.26 | 0.24 | 0.22 | 0.04 | -0.05 | 0.08 | -0.02 |
| Weighted Avg Shares Out | 131.98M | 526.85M | 526.85M | 526.93M | 526.88M | 526.55M | 525.80M | 521.60M | 522.78M | 528.29M | 525.79M | 538.72M | 540.56M | 436.77M | 403.30M | 540.90M | 540.90M |
| Weighted Avg Shares Out (Dil) | 131.98M | 527.57M | 527.42M | 527.67M | 527.56M | 527.22M | 532.45M | 526.93M | 526.72M | 530.08M | 530.27M | 546.27M | 541.92M | 436.91M | 403.30M | 540.90M | 540.90M |
Extraordinary dividend
Chr. Hansen Holding A/S' (CHYHY) CEO Mauricio Graber on Q1 2021 Results - Earnings Call Transcript
Chr. Hansen Holding A/S Interim report Q1 2020/21
Goldman Sachs Group Upgrades Chr. Hansen Holding A/S (OTCMKTS:CHYHY) to Neutral
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) Given Consensus Recommendation of “Hold” by Analysts
Chr. Hansen Holding A/S (OTCMKTS:CHYHY) Given “Neutral” Rating at Credit Suisse Group
Source: https://incomestatements.info
Category: Stock Reports